Pressure Biosciences Company Profile (OTCMKTS:PBIO)

About Pressure Biosciences (OTCMKTS:PBIO)

Pressure Biosciences logoPressure BioSciences, Inc. is focused on solving the problems inherent in biological sample preparation. The Company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels, such as approximately 35,000 pounds per square inch (psi) or greater to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant and microbial sources. Its laboratory instrument, the Barocycler, and its consumables product line, which include its Pressure Used to Lyse Samples for Extraction (PULSE) tubes, and other processing tubes, and application specific kits, such as consumable products and reagents, together make up its PCT Sample Preparation System (PCT SPS). The Company is also the distributor for the Constant Systems cell disruption equipment, parts, and consumables.

Industry, Sector and Symbol: Average Prices:
  • 50 Day Moving Avg: $0.26
  • 200 Day Moving Avg: $0.25
  • 52 Week Range: $0.15 - $0.46
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.38
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $2.02 million
  • Price / Sales: 0.12
  • Book Value: ($12.70) per share
  • Price / Book: -0.02
Profitability:
  • EBIDTA: ($3,670,000.00)
  • Net Margins: -1,014.68%
  • Return on Assets: -1,295.65%
Debt:
  • Debt-to-Equity Ratio: -0.06%
  • Current Ratio: 0.13%
  • Quick Ratio: 0.06%
Misc:
  • Average Volume: 78,205 shs.
  • Beta: 2.07
  • Short Ratio: 0.04
 

Frequently Asked Questions for Pressure Biosciences (OTCMKTS:PBIO)

What is Pressure Biosciences' stock symbol?

Pressure Biosciences trades on the OTCMKTS under the ticker symbol "PBIO."

How were Pressure Biosciences' earnings last quarter?

Pressure Biosciences Inc (OTCMKTS:PBIO) posted its quarterly earnings data on Tuesday, May, 16th. The company reported ($0.18) earnings per share for the quarter. The firm had revenue of $0.55 million for the quarter. View Pressure Biosciences' Earnings History.

Who are some of Pressure Biosciences' key competitors?

Who are Pressure Biosciences' key executives?

Pressure Biosciences' management team includes the folowing people:

  • Jeffery N. Peterson, Independent Chairman of the Board
  • Richard T. Schumacher, President, Chief Executive Officer, Treasurer, Secretary, Clerk, Director
  • Joseph L. Damasio Jr., Chief Financial Officer, Vice President - Finance
  • Edmund Y. Ting Ph.D., Senior Vice President - Engineering
  • Nathan P. Lawrence Ph.D., Vice President of Sales and Marketing
  • Alexander V. Lazarev Ph.D., Vice President - Research & Development
  • Michael S. Urdea, Director
  • Vito J. Mangiardi, Independent Director
  • Kevin A. Pollack, Independent Director

How do I buy Pressure Biosciences stock?

Shares of Pressure Biosciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pressure Biosciences' stock price today?

One share of Pressure Biosciences stock can currently be purchased for approximately $0.22.


MarketBeat Community Rating for Pressure Biosciences (OTCMKTS PBIO)
Community Ranking:  2.7 out of 5 ( )
Outperform Votes:  6 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  11
MarketBeat's community ratings are surveys of what our community members think about Pressure Biosciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Pressure Biosciences (OTCMKTS:PBIO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Pressure Biosciences (OTCMKTS:PBIO)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Pressure Biosciences (OTCMKTS:PBIO)
Earnings by Quarter for Pressure Biosciences (OTCMKTS:PBIO)
Earnings History by Quarter for Pressure Biosciences (OTCMKTS PBIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/16/2017Q1 2017($0.18)$0.55 millionViewN/AView Earnings Details
8/17/2015($0.04)($0.09)$0.58 million$0.41 millionViewN/AView Earnings Details
4/1/2015($0.07)($0.09)$0.50 million$0.29 millionViewN/AView Earnings Details
11/17/2014($0.11)($0.07)$0.46 million$0.37 millionViewN/AView Earnings Details
8/14/2014($0.11)($0.05)$0.39 million$0.31 millionViewN/AView Earnings Details
5/15/2014($0.10)($0.25)$0.34 million$0.40 millionViewN/AView Earnings Details
4/2/2014($0.07)($0.14)ViewN/AView Earnings Details
8/15/2013Q2 2013($0.06)($0.10)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pressure Biosciences (OTCMKTS:PBIO)
Current Year EPS Consensus Estimate: $-0.28 EPS
Next Year EPS Consensus Estimate: $-0.16 EPS

Dividends

Dividend History for Pressure Biosciences (OTCMKTS:PBIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Pressure Biosciences (OTCMKTS:PBIO)
Insider Ownership Percentage: 20.80%
Insider Trades by Quarter for Pressure Biosciences (OTCMKTS:PBIO)
Insider Trades by Quarter for Pressure Biosciences (OTCMKTS:PBIO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/26/2014Richard T SchumacherCEOBuy13,200$0.30$3,960.00View SEC Filing  
9/13/2013Richard T SchumacherCEOBuy2,500$0.31$775.00View SEC Filing  
9/12/2013Richard T SchumacherCEOBuy20,500$0.30$6,150.00View SEC Filing  
9/9/2013Richard T SchumacherCEOBuy15,500$0.28$4,340.00View SEC Filing  
8/30/2013Michael S UrdeaDirectorBuy50,000$0.29$14,500.00View SEC Filing  
8/30/2013Richard T SchumacherCEOBuy10,000$0.29$2,900.00View SEC Filing  
8/28/2013Richard T SchumacherCEOBuy15,000$0.28$4,200.00View SEC Filing  
8/23/2013Richard T SchumacherCEOBuy20,000$0.27$5,400.00View SEC Filing  
8/21/2013Kevin PollackDirectorBuy10,000$0.28$2,800.00View SEC Filing  
10/8/2012Clayton A StruveMajor ShareholderBuy76,350$0.38$29,013.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Pressure Biosciences (OTCMKTS:PBIO)
Latest Headlines for Pressure Biosciences (OTCMKTS:PBIO)
Source:
DateHeadline
finance.yahoo.com logoDr. Ruedi Aebersold Receives the Prestigious Karger Medal Recognizing an Individual Who Has Significantly Contributed to the Development of New Bioanalytical Methods
finance.yahoo.com - June 5 at 7:45 PM
finance.yahoo.com logoPressure BioSciences, Inc. Announces One-for-Thirty Reverse Stock Split
finance.yahoo.com - June 2 at 9:34 PM
finance.yahoo.com logoPBIO: Significant Revenue Growth Expected for 2017 and Beyond
finance.yahoo.com - June 1 at 3:25 PM
finance.yahoo.com logoPressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017
finance.yahoo.com - May 26 at 8:20 PM
americanbankingnews.com logoPressure Biosciences Inc (PBIO) Releases Quarterly Earnings Results
www.americanbankingnews.com - May 17 at 10:54 AM
finance.yahoo.com logoPressure BioSciences, Inc. Reports First Quarter 2017 Financial Results and Provides Business Update
finance.yahoo.com - May 16 at 6:49 PM
finance.yahoo.com logoPressure BioSciences, Inc. to Discuss First Quarter 2017 Financial Results and Provide Business Update
finance.yahoo.com - May 15 at 6:24 PM
finance.yahoo.com logoPressure BioSciences, Inc. Appoints Joseph L. Damasio Jr. as Vice President of Finance and Chief Financial Officer
finance.yahoo.com - April 17 at 9:38 AM
finance.yahoo.com logoWallStreet Research(TM) Announces Availability of Updated Corporate Profile Coverage on Pressure BioSciences, Inc. (OTCQB: PBIO)
finance.yahoo.com - March 29 at 9:13 AM
finance.yahoo.com logoPRESSURE BIOSCIENCES INC Financials
finance.yahoo.com - March 28 at 6:54 PM
finance.yahoo.com logoPressure BioSciences, Inc. Significantly Expands Marketing and Sales Capabilities
finance.yahoo.com - March 23 at 7:38 PM
finance.yahoo.com logoPressure BioSciences, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Provides Business Update
finance.yahoo.com - March 22 at 7:07 PM
biz.yahoo.com logoPRESSURE BIOSCIENCES INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 22 at 7:07 PM
finance.yahoo.com logoPressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2016 Financial Results and Provide Business Update
finance.yahoo.com - March 21 at 11:07 AM
bizjournals.com logoFinancialBuzz.com Innovation in the Sample Preparation Market
www.bizjournals.com - March 1 at 10:17 AM
finance.yahoo.com logoPressure BioSciences Receives 2017 North American Excellence Award: "Best New Instrument for Sample Preparation"
finance.yahoo.com - March 1 at 10:17 AM
finance.yahoo.com logoPressure BioSciences Ramps Up Commercialization of Next-Generation Instrument with CE Marking -- SECFilings.com
finance.yahoo.com - February 9 at 8:38 PM
finance.yahoo.com logoPressure BioSciences, Inc. Discusses Research Market, Goals and Milestones for First Half of 2017 in New SNNLive Video Interview with StockNewsNow.com
finance.yahoo.com - February 8 at 8:06 PM
finance.yahoo.com logoPressure BioSciences Achieves CE Marking for its Next Generation Sample Preparation Instrument, the Barocycler 2320EXTREME
finance.yahoo.com - February 2 at 8:02 PM
finance.yahoo.com logoPressure BioSciences, Inc. to Present at RedChip's Global Online Growth Conference
finance.yahoo.com - January 24 at 7:53 PM
finance.yahoo.com logoPressure BioSciences, Inc. to Present at the 2017 Biotech Showcase
finance.yahoo.com - January 10 at 7:59 PM
biz.yahoo.com logoPRESSURE BIOSCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - January 3 at 11:45 PM
finance.yahoo.com logoPressure BioSciences, Inc. Well Positioned to Play Important Role in US's $1.8 Billion "Cancer Moonshot" Initiative
finance.yahoo.com - December 16 at 7:53 PM
finance.yahoo.com logoKaryopharm Therapeutics CEO And CFO Talk Company Finances, Partnerships And Pipeline
finance.yahoo.com - December 7 at 7:02 PM
finance.yahoo.com logoPressure Biosciences CEO On Biological Samples: It's All About How You Break Open A Cell
finance.yahoo.com - December 5 at 7:04 PM
finance.yahoo.com logoWallStreet Research Announces Availability of Updated Corporate Profile Coverage On Pressure BioSciences, Inc. (OTCQB: PBIO)
finance.yahoo.com - November 21 at 12:01 PM
finance.yahoo.com logoPressure BioSciences (PBIO) Achieves Record Revenue on Road to Profitability -- SECFilings.com
finance.yahoo.com - November 21 at 12:01 PM
finance.yahoo.com logoPBIO: Update on Third Quarter Financials
finance.yahoo.com - November 21 at 12:01 PM
finance.yahoo.com logoPressure BioSciences, Inc. Reports Third Quarter 2016 Financial Results and Provides Business Update
finance.yahoo.com - November 16 at 7:02 PM
biz.yahoo.com logoQ3 2016 Pressure Biosciences Inc Earnings Release - Time Not Supplied
biz.yahoo.com - November 16 at 10:27 AM
finance.yahoo.com logo9:19 am Pressure BioSciences announces the initial close of $610K in gross proceeds in a $2.5 mln private placement
finance.yahoo.com - November 14 at 7:01 PM
finance.yahoo.com logoPressure BioSciences Announces Initial Close of $610,000 in $2.5 Million Private Placement
finance.yahoo.com - November 14 at 10:50 AM
finance.yahoo.com logoPressure BioSciences, Inc. to Discuss Third Quarter 2016 Financial Results and Provide Business Update
finance.yahoo.com - November 11 at 6:31 PM
finance.yahoo.com logoPressure BioSciences (PBIO) Secures Funding Allowing for Accelerated Corporate Development -- SECFilings.com
finance.yahoo.com - November 4 at 10:21 AM
finance.yahoo.com logoPressure BioSciences, Inc. Closes $2,000,000 Line-of-Credit
finance.yahoo.com - November 3 at 10:49 AM
finance.yahoo.com logoHow to Invest in the Cancer Moonshot -- SECFilings.com
finance.yahoo.com - October 27 at 11:37 AM
finance.yahoo.com logoPressure BioSciences' PCT Platform Featured at Official Launch of Major Cancer Research Center Recently Chosen as a Collaborator in the US "Cancer Moonshot" Initiative
finance.yahoo.com - October 26 at 6:45 PM
finance.yahoo.com logoPressure BioSciences, Inc. to Present at the Fall SeeThruEquity Microcap Investment Conference in New York City
finance.yahoo.com - October 17 at 11:49 AM
finance.yahoo.com logoPBIO: Revenue Continues to Grow Nicely for Second Quarter 2016
finance.yahoo.com - August 17 at 7:02 PM
finance.yahoo.com logoPressure BioSciences Announces Initial Shipments of its Enabling, Next-Generation PCT System
finance.yahoo.com - July 21 at 10:48 AM

Social

Chart

Pressure Biosciences (PBIO) Chart for Thursday, June, 22, 2017

This page was last updated on 6/22/2017 by MarketBeat.com Staff